{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-034216","form_type":"8-K","ticker":"CELU","cik":"0001752828","company_name":"Celularity Inc","filed_at":"2024-08-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.409222+00:00","generated_at":"2026-05-31T07:12:38.864500+00:00","sec_items":["5.02","7.01","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Celularity appoints Richard J. Berman to Board; reduces board from 7 to 6","bullets":["Richard J. Berman appointed as Class II director, effective Aug 27, 2024, to fill vacancy left by Robin L. Smith.","Berman received an option to purchase 118,111 shares at $3.01/share, vesting in three equal annual installments.","Board reduced from seven to six directors following Marc Mazur's departure; Class III reduced from two to one.","Berman brings over 40 years of VC and M&A experience; served on boards of six companies over $1B market value.","He was appointed to the Audit Committee; qualifies as independent under Nasdaq rules."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-034216","json":"https://secwatch.observer/filing/0001493152-24-034216.json","markdown":"https://secwatch.observer/filing/0001493152-24-034216.md","text":"https://secwatch.observer/filing/0001493152-24-034216.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1752828/000149315224034216/0001493152-24-034216-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1752828/000149315224034216/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:12:38.864500+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"89b8fb5a2f","claim":"Richard J. Berman was appointed as Director at Celularity Inc.","evidence_excerpt":"On August 27, 2024, the board of directors, or the Board, of Celularity Inc., or Celularity, appointed Richard J. Berman, as a Class II director to fill the vacancy left by the resignation of Robin L. Smith, M.D.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315224034216/0001493152-24-034216-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}